SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Caplin Point Laboratories informs about press release

09 Dec 2025 Evaluate

Caplin Point Laboratories has informed that it enclosed Press Release on the company’s Subsidiary, Caplin Steriles, getting USFDA approval for its ANDA Linezolid Injection 600 mg/ 300 mL (2 mg/mL) Single Dose Infusion Bags.

The above information is a part of company’s filings submitted to BSE.

Caplin Point Lab Share Price

2369.60 36.35 (1.56%)
18-Jun-2026 12:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1815.20
Dr. Reddys Lab 1264.15
Cipla 1353.10
Zydus Lifesciences 1068.60
Lupin 2294.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: